Familial Hypertriglyceridemia Latest Advances

Find the Latest Research About Familial Hypertriglyceridemia

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10796 publications

Clinical effects of apolipoprotein C3 inhibitors on triglyceride levels and pancreatitis risk: a systematic review and meta-analysis.

Clinical effects of apolipoprotein C3 inhibitors on triglyceride levels and pancreatitis risk: a systematic review and meta-analysis.

Journal: Minerva endocrinology
Published: June 22, 2026

Comparative efficacy and safety of olezarsen versus volanesorsen for familial chylomicronemia syndrome: a matching-adjusted indirect comparison.

Comparative efficacy and safety of olezarsen versus volanesorsen for familial chylomicronemia syndrome: a matching-adjusted indirect comparison.

Journal: Journal of comparative effectiveness research
Published: June 19, 2026

Heterozygosity for pathogenic variants in familial chylomicronemia syndrome genes: from carrier state to complex trait.

Heterozygosity for pathogenic variants in familial chylomicronemia syndrome genes: from carrier state to complex trait.

Journal: Current opinion in lipidology
Published: June 17, 2026

A Case of Familial Chylomicronemia Syndrome Caused by a Novel Homozygous GPIHBP1 Mutation Successfully Treated with the Selective PPARα Modulator Pemafibrate.

A Case of Familial Chylomicronemia Syndrome Caused by a Novel Homozygous GPIHBP1 Mutation Successfully Treated with the Selective PPARα Modulator Pemafibrate.

Journal: Journal of atherosclerosis and thrombosis
Published: June 17, 2026

Preservation of muscle mass assessed by ultrasound during a meal replacement-based hypocaloric intervention in obese individuals: a real-world clinical trial.

Preservation of muscle mass assessed by ultrasound during a meal replacement-based hypocaloric intervention in obese individuals: a real-world clinical trial.

Journal: Nutricion hospitalaria
Published: June 16, 2026

A cross-sectional survey on uncooked corn starch application and gastrointestinal complications in children with hepatic glycogen storage disease

A cross-sectional survey on uncooked corn starch application and gastrointestinal complications in children with hepatic glycogen storage disease

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: June 16, 2026

Olezarsen for Hypertriglyceridemia: A New Therapy Update with Systematic Review and Meta-Analysis.

Olezarsen for Hypertriglyceridemia: A New Therapy Update with Systematic Review and Meta-Analysis.

Journal: Cardiology in review
Published: June 16, 2026

Association of ultra-processed foods (UPFs) with hypertriglyceridemic waist (HTGW) phenotype, oxidative stress, and inflammation in Iranian adults: a cross-sectional study.

Association of ultra-processed foods (UPFs) with hypertriglyceridemic waist (HTGW) phenotype, oxidative stress, and inflammation in Iranian adults: a cross-sectional study.

Journal: Food & function
Published: June 16, 2026

Design and Development of a Novel LXRβ/PPARδ Dual Agonist for Memory Impairment and Pathology in 3xTg-AD Animal Model of Alzheimer's Disease.

Design and Development of a Novel LXRβ/PPARδ Dual Agonist for Memory Impairment and Pathology in 3xTg-AD Animal Model of Alzheimer's Disease.

Journal: ACS chemical biology
Published: June 15, 2026

Sex- and Age-specific Divergent Trends in Walking, Obesity, and Hypertriglyceridemia in Middle-Aged Adults: A Joinpoint Regression Analysis, 2005-2023.

Sex- and Age-specific Divergent Trends in Walking, Obesity, and Hypertriglyceridemia in Middle-Aged Adults: A Joinpoint Regression Analysis, 2005-2023.

Journal: Inquiry : a journal of medical care organization, provision and financing
Published: June 11, 2026

Metabolic syndrome and cardiovascular risk among people living with HIV in Southwest Goiás, Brazil: A cross-sectional study.

Metabolic syndrome and cardiovascular risk among people living with HIV in Southwest Goiás, Brazil: A cross-sectional study.

Journal: AIDS care
Published: June 10, 2026

ApoC[III] You Later: A Review of Plozasiran for the Management of Familial Chylomicronemia Syndrome.

ApoC[III] You Later: A Review of Plozasiran for the Management of Familial Chylomicronemia Syndrome.

Journal: The Annals of pharmacotherapy
Published: June 06, 2026
Showing 1-12 of 10,796

Last Updated: 06/30/2026